In this task, you are given a summary for US Congressional and California state bill, your task is to generate a Title for this bill. The preferred titles are under forty words and mention the purpose of the bill.

Q: Angie Fatino Save Our Children from Meth Act of 2005 - Amends the Controlled Substances Act to direct the Attorney General to transfer to schedule V ephedrine, pseudoephedrine, and phenylpropanolamine. Makes this provision inapplicable with respect to pseudoephedrine when contained in a product that is in a liquid, liquid capsule, or liquid-filled gel capsule, that does not contain more than 360 milligrams of pseudoephedrine, and that is approved under the Federal Food, Drug, and Cosmetic Act (pseudoephedrine contained in such product shall then be considered a list I chemical).

Revises the definition of "regulated transaction" to exclude specified transactions involving drugs or products that the Attorney General determines are being diverted for illicit purposes.

Places restrictions on the sale of list I and schedule V pseudoephedrine products. Requires a registrant of list I products to: (1) place the products where the customers do not have direct access to them; (2) maintain a sales logbook that identifies the products, purchasers, dates, and times of sales; and (3) not sell such a product to persons under age 18. Prohibits a registrant of schedule V products that do not require prescriptions from dispensing such a product to a prospective purchaser under age 18.

Sets penalties for violations.

Prohibits any person from knowingly or intentionally purchasing at retail: (1) more than one list I pseudoephedrine product during a 24-hour period without a prescription; (2) more than 7,500 milligrams of pseudoephedrine in list I or schedule V products during a 30-day period without a prescription; or (3) such a list I product without legibly signing the appropriate logbook.

A: To amend the Controlled Substances Act to provide for the transfer of ephedrine, pseudoephedrine, and phenylpropanolamine to schedule V of the schedules of controlled substances, and for other purposes.
****
Q: Preserving Access to Life-Saving Medications Act - Amends the Federal Food, Drug, and Cosmetic Act to require a prescription drug manufacturer to notify the Secretary of Health and Human Services (HHS) of a discontinuance, interruption, or other adjustment of the manufacture of the drug that would likely result in a shortage of such drug. Requires: (1) six months notice of any discontinuance or planned interruption or adjustment, and (2) notice as soon as practicable after becoming aware of such interruption or adjustment in the case of any other interruption or adjustment. Applies this Act to any approved prescription drug that is not a product that was originally derived from human tissue and was replaced by a recombinant product.

Sets forth the types of adjustment for which a manufacturer must submit notice, including: (1) adjustments related to the supply of raw materials, (2) adjustments to production capabilities, (3) business decisions that may affect the manufacture of the drug, and (4) other adjustments as determined appropriate by the Secretary.

A: A bill to amend the Federal Food, Drug, and Cosmetic Act to provide the Food and Drug Administration with improved capacity to prevent drug shortages.
****
Q: Earthquake Hazards Reduction Authorization Act of 1999 - Amends the Earthquake Hazards Reduction Act of 1977 to authorize appropriations to the Federal Emergency Management Agency (FEMA) for earthquake hazards reduction for FY 2000 and 2001. Authorizes appropriations for FY 2000 and 2001 to the Secretary of the Interior for carrying out, through the Director of the U.S.  Geological Survey (USGS), responsibilities assigned under the Act, with specified amounts available for the Global Seismic Network and the Scientific Earthquake Studies Advisory Committee.  Makes specified amounts available for FY 2000 and 2001 for a related USGS grant program. Authorizes additional appropriations for FY 2000 and 2001 for a USGS program to develop a prototype real-time seismic warning system. Authorizes appropriations under the Act for FY 2000 and 2001 for National Science Foundation (NSF) engineering and geosciences research and for the National Institute of Standards and Technology. Repeals a provision regarding non-Federal cost sharing for supplemental funds. Requires the USGS Director to: (1) establish an Advanced National Seismic Research and Monitoring System to modernize, standardize, and stabilize the national, regional, and urban seismic monitoring systems in the United States into a coordinated system; and (2) transmit a five-year management plan for the System to Congress.  Authorizes appropriations. Requires the NSF Director to establish a Network for Earthquake Engineering Simulation that will upgrade, link, and integrate a system of geographically distributed experimental facilities for earthquake engineering testing of full-sized structures and their components and partial-scale physical models.   Authorizes appropriations. Requires the USGS Director to establish a Scientific Earthquake Studies Advisory Committee. Requires the FEMA Director to report to Congress on elements of the earthquake hazards reduction program that specifically address the needs of at-risk populations, including the elderly, persons with disabilities, non-English-speaking families, single-parent households, and the poor.  Requires such report to make recommendations for additional legislative authority required to address such needs. Sets forth Buy American requirements with respect to assistance expended by entities under this Act.  Expresses the sense of Congress that entities receiving assistance under this Act should purchase only American-made equipment and products with such assistance. Makes persons who have labeled products not made in the United States as "Made in America" ineligible for contracts made with funds provided by this Act.

A:
Earthquake Hazards Reduction Authorization Act of 1999
****